XB
Xenetic Biosciences, Inc.
XBIO · NASDAQ
$2.99 +6.41% (+$0.18)
1M -21.52%
Market Cap $6.85M
P/E Ratio -
Div. Yield -
ROE 40.62%
Bulios Fair Price
$3.8
27.1% upside
Trenutna cena
$2.99
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica XBIO trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
87 /100
Cheap P/B 1.13x
P/S 2.10x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 18.47%
Rev. growth 20.36%
FCF growth N/A
Profitability
20 /100
Weak Net margin 75.91%
Op. margin 81.01%
FCF margin 70.93%
Quality
6 /100
Poor ROE 40.62%
ROA 35.52%
Asset turnover 0.47x
Debt
100 /100
Low Current ratio 7.43x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
40 /100
Moderate Rev. volatility 25.32%
EPS volatility 19.59%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o XBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
James F. Parslow
Employees
2
Headquarters
Framingham
Prihajajoči dogodki
06 NOV.
Earnings
Upcoming earnings report